A new Pharmaceutical Price Regulation Scheme (PPRS) came into effect in the U.K. on January 1, 2009. The new PPRS represents the latest version of the profit control system which has been negotiated at regular intervals for over 50 years between the U.K. government and the Association of the British Pharmaceutical Industry (ABPI).

The U.K. Department of Health stated that the new agreement "means that more patients will benefit from a wider range of innovative drug treatments at a fair price." Among other things, it will continue to allow innovative manufacturers freedom to establish the launch price of new drugs and provide for modulated price cuts for existing drugs.

For a report on the new PPRS, please visit: